-
Sabalenka roars back to make Berlin WTA semis
-
Europe swelters as more heat records set to tumble
-
Narvaez takes Swiss Tour third stage after 100km breakaway
-
'There's no soul': Tony Leung weighs in on AI in filmmaking
-
Europe swelters as temperature records tumble
-
From Versailles to a Swiss mountain: a week of dizzying Iran diplomacy
-
French mountain lodges worry over strained water supply
-
Coach tells S. Korea to move on fast with World Cup knockouts in reach
-
Heatwave hits more than one in two people in France
-
Henry strikes as New Zealand strengthen grip against England
-
Zverev sets up Fritz semi at Halle Open
-
England captain Stokes in action for Durham as Test recall looms
-
Clark stumbles but still leads by two at US Open
-
Moutet fined over x-rated Queen's Club rant
-
Ogura pulls off stunner to top Czech MotoGP practices
-
Outrage in Italy after Trump says Meloni 'begged' for photo op
-
Turkey bars public World Cup screening over university entrance exam
-
From birds to fish, how extreme heat causes wildlife to suffer
-
Ebola spreading 'fast' in DR Congo, warns WHO
-
Trapped on Everest for days, Nepali survivor recounts escape
-
The Sun may not engulf Earth after all, scientists say
-
Clark leads by three as US Open second round begins
-
Russia signals slower rate cuts amid high Ukraine war spending
-
Fritz gets revenge on Shelton to reach Halle semis
-
Henry strikes as New Zealand lead England by 100 runs in 2nd Test
-
Heatwave hits more than half of France's population
-
Online threats, insults fuel S.Africa's anti-foreigner hate
-
Former England keeper Earps agrees to join London City Lionesses
-
Clark completes first round with two-stroke US Open lead
-
Olympic hurdles medallist Bascou suspended for doping
-
Italian FM cancels US visit over reported Trump comments
-
Pegula sinks Keys to reach Berlin Open semis
-
Oil prices, shares steady after US-Iran talks postponed
-
Gaza ceasefire a 'deadly illusion': UNICEF
-
What did we learn from the hantavirus cruise ship scare?
-
S.Africa anti-migrant hate loses team African support at World Cup
-
Arsenal will start Premier League title defence against Coventry
-
European robotics start-ups go up against Chinese heavyweights
-
'Alter-Ego': An Italian hospital's little robot carer
-
Japan's men told to clean at home, not just the World Cup
-
French court confirms Moroccan football star Hakimi will stand trial for rape
-
South Korean leader says told Trump sanctions on North are 'ineffective'
-
Deadly Philippines quake turns seabed into shore
-
Stocks rally falters, oil rises as US-Iran talks postponed
-
S. Korean leader says he told Trump sanctions on North are 'ineffective'
-
Indonesia to capture last-known wild Bornean rhino for IVF
-
No vaccine, conflict, mistrust: Ebola's return to DR Congo
-
USA, Australia eye World Cup knockout rounds, Brazil in action
-
AI museum brings sights, sounds and smells of the rainforest
-
Iran to lodge complaint with FIFA over World Cup restrictions
Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
P.Vogel--VB